IBDEI307 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47968,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,47968,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,47969,0)
 ;;=I95.1^^185^2414^51
 ;;^UTILITY(U,$J,358.3,47969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47969,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,47969,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,47969,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,47970,0)
 ;;=I95.89^^185^2414^52
 ;;^UTILITY(U,$J,358.3,47970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47970,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,47970,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,47970,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,47971,0)
 ;;=I25.9^^185^2414^53
 ;;^UTILITY(U,$J,358.3,47971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47971,1,3,0)
 ;;=3^Ischemic Heart Disease,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,47971,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,47971,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,47972,0)
 ;;=I89.0^^185^2414^54
 ;;^UTILITY(U,$J,358.3,47972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47972,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,47972,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,47972,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,47973,0)
 ;;=R01.1^^185^2414^55
 ;;^UTILITY(U,$J,358.3,47973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47973,1,3,0)
 ;;=3^Murmur,Cardia,Unspec
 ;;^UTILITY(U,$J,358.3,47973,1,4,0)
 ;;=4^R01.1
 ;;^UTILITY(U,$J,358.3,47973,2)
 ;;=^5019169
 ;;^UTILITY(U,$J,358.3,47974,0)
 ;;=I21.3^^185^2414^56
 ;;^UTILITY(U,$J,358.3,47974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47974,1,3,0)
 ;;=3^Myocardial Infarction,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,47974,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,47974,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,47975,0)
 ;;=I25.2^^185^2414^57
 ;;^UTILITY(U,$J,358.3,47975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47975,1,3,0)
 ;;=3^Myocardial Infarction,Old
 ;;^UTILITY(U,$J,358.3,47975,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,47975,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,47976,0)
 ;;=I78.1^^185^2414^58
 ;;^UTILITY(U,$J,358.3,47976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47976,1,3,0)
 ;;=3^Nevus,Non-Neoplastic
 ;;^UTILITY(U,$J,358.3,47976,1,4,0)
 ;;=4^I78.1
 ;;^UTILITY(U,$J,358.3,47976,2)
 ;;=^269807
 ;;^UTILITY(U,$J,358.3,47977,0)
 ;;=Z95.0^^185^2414^65
 ;;^UTILITY(U,$J,358.3,47977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47977,1,3,0)
 ;;=3^Presence of Cardiac Pacemaker
 ;;^UTILITY(U,$J,358.3,47977,1,4,0)
 ;;=4^Z95.0
 ;;^UTILITY(U,$J,358.3,47977,2)
 ;;=^5063668
 ;;^UTILITY(U,$J,358.3,47978,0)
 ;;=I73.9^^185^2414^59
 ;;^UTILITY(U,$J,358.3,47978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47978,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,47978,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,47978,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,47979,0)
 ;;=I80.9^^185^2414^60
 ;;^UTILITY(U,$J,358.3,47979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47979,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,47979,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,47979,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,47980,0)
 ;;=Z98.61^^185^2414^61
 ;;^UTILITY(U,$J,358.3,47980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47980,1,3,0)
 ;;=3^Postprocedural State,Coronary Angioplasty
 ;;^UTILITY(U,$J,358.3,47980,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,47980,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,47981,0)
 ;;=Z98.62^^185^2414^62
